Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 2
2006 2
2007 7
2008 4
2009 1
2010 2
2011 6
2012 6
2013 5
2014 7
2015 4
2016 7
2017 6
2018 6
2019 5
2020 2
2021 2
2022 5
2023 6
2024 7
2025 9
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Expert consensus on cancer treatment-related lung injury.
Lin X, Guo H, Zhao W, Li M, Lin G, Chu Q, Chen E, Chen L, Chen R, Chu T, Deng H, Deng Y, Dong H, Dong W, Dong Y, Fang W, Gan X, Gong L, Gu Y, Han Q, Hao Y, He Y, Hu C, Hu J, Hu Y, Jiang Y, Jin Y, Lan F, Li W, Li W, Liang W, Liu A, Liu D, Liu M, Liu M, Liu Z, Liu Z, Luo Q, Miao L, Mu C, Pan P, Peng P, Qin J, Qin Y, Shen P, Shi M, Song Y, Su C, Su J, Su X, Tan X, Tang K, Tang X, Tian P, Wang B, Wang H, Wang K, Wang M, Wang Q, Wang W, Wang Z, Wu D, Xu F, Xu Y, Xu C, Xie Z, Xie X, Yang B, Yang M, Ye F, Ye X, Yu Z, Zhang J, Zhang J, Zhang X, Zhao F, Zheng X, Zhu B, Zhu Z, Zhou J, Zhou J, Zhou M, Zhou Q, Zou Z, Kidane B, Bignami E, Sakamaki F, Roviello G, Taniguchi H, Jeon K, Saric L, Ariza-Prota M, La-Beck NM, Kanaji N, Watanabe S, Shukuya T, Akaba T, Leong TL, Gesierich W, Koga Y, Tanino Y, Uehara Y, Li S, Chen R, Zhou C. Lin X, et al. Among authors: kanaji n. J Thorac Dis. 2025 Apr 30;17(4):1844-1875. doi: 10.21037/jtd-2025-292. Epub 2025 Apr 28. J Thorac Dis. 2025. PMID: 40400937 Free PMC article. Review.
Prevalence and clinical features of interstitial lung disease in patients with psoriasis.
Kanaji N, Misaki N, Murota M, Iwata M, Ishikawa R, Yamamura K, Tanaka H, Yokota N, Fujimoto S, Yajima T, Dobashi H, Shimada H, Wakiya R, Watanabe N, Inoue T, Mizoguchi H, Komori Y, Kojima K, Kadowaki N, Dainichi T. Kanaji N, et al. BMC Pulm Med. 2024 Dec 18;24(1):610. doi: 10.1186/s12890-024-03450-7. BMC Pulm Med. 2024. PMID: 39695614 Free PMC article.
Paraneoplastic syndromes associated with lung cancer.
Kanaji N, Watanabe N, Kita N, Bandoh S, Tadokoro A, Ishii T, Dobashi H, Matsunaga T. Kanaji N, et al. World J Clin Oncol. 2014 Aug 10;5(3):197-223. doi: 10.5306/wjco.v5.i3.197. World J Clin Oncol. 2014. PMID: 25114839 Free PMC article. Review.
Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring EGFR Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED).
Ishihara M, Kawamura T, Namba Y, Takeyasu Y, Hasegawa Y, Sato Y, Negi Y, Oba T, Sumi T, Hirata H, Funabashi H, Oya Y, Kikuchi H, Katsurada N, Nakatani T, Tanimura K, Nakagawa T, Takeda N, Asami T, Honjo O, Nagashima H, Yamaura T, Hata N, Kitazono M, Nishioka N, Tamiya A, Sakamori Y, Shigaki R, Kaira K, Honda R, Matsui T, Suzuki E, Ito K, Otsuka K, Takase N, Murakami Y, Matsuno K, Inoue S, Kisohara A, Kusumoto S, Aoshima H, Kakizaki Y, Kubo A, Hata A, Ishikawa N, Hamai K, Kanaji N, Misumi T, Matsutani N, Seki N. Ishihara M, et al. Among authors: kanaji n. Ther Adv Med Oncol. 2025 Jun 16;17:17588359251344010. doi: 10.1177/17588359251344010. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 40535732 Free PMC article.
The clinical potential of HMGB1 for the risk assessment of severe checkpoint inhibitor pneumonitis: A prospective multicenter study (CS-Lung004).
Yamaguchi K, Takao S, Kanaji N, Hirakawa T, Matsumoto N, Miyazaki K, Okimoto T, Ando C, Higo H, Yanai M, Nagasaki Y, Kurose K, Watanabe M, Oyama K, Toyoda Y, Ono S, Tada S, Iwamoto H, Hattori N. Yamaguchi K, et al. Among authors: kanaji n. Eur J Cancer. 2025 Aug 26;226:115606. doi: 10.1016/j.ejca.2025.115606. Epub 2025 Jul 5. Eur J Cancer. 2025. PMID: 40639019 Free article.
An Uncharted Constellation: TAFRO Syndrome.
Tadokoro A, Kanaji N, Hara T, Matsumoto K, Ishii T, Takagi T, Watanabe N, Kita N, Kawauchi M, Ueno M, Kadowaki N, Bandoh S. Tadokoro A, et al. Among authors: kanaji n. Am J Med. 2016 Sep;129(9):938-41. doi: 10.1016/j.amjmed.2016.05.010. Epub 2016 Jun 4. Am J Med. 2016. PMID: 27267287 No abstract available.
Hairy cell leukaemia with an IGH-BRAF fusion gene.
Matsumoto K, Kakazu N, Imataki O, Kondo A, Kanaji N, Kadowaki N. Matsumoto K, et al. Among authors: kanaji n. Br J Haematol. 2023 Sep;202(6):e67-e70. doi: 10.1111/bjh.18980. Epub 2023 Jul 11. Br J Haematol. 2023. PMID: 37433466 No abstract available.
Promising Effectiveness of Combined Chemotherapy and Immunotherapy in Patients with Advanced Non-small Cell Lung Cancer: A Real-World Prospective Observational Study (CS-Lung-003).
Kanaji N, Nishii K, Tsubata Y, Nakao M, Okuno T, Okawa S, Takata K, Kodani M, Yamasaki M, Fujitaka K, Kubota T, Inoue M, Watanabe N, Hotta K; CS-Lung-003 Investigator. Kanaji N, et al. Acta Med Okayama. 2025 Jun;79(3):167-176. doi: 10.18926/AMO/68724. Acta Med Okayama. 2025. PMID: 40574255 Free article.
Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis.
Matsuda Y, Ye J, Yamakawa K, Mukai Y, Azuma K, Wu L, Masutomi K, Yamashita T, Daigo Y, Miyagi Y, Yokose T, Oshima T, Ito H, Morinaga S, Kishida T, Minamoto T, Kojima M, Kaneko S, Haba R, Kontani K, Kanaji N, Okano K, Muto-Ishizuka M, Yokohira M, Saoo K, Imaida K, Suizu F. Matsuda Y, et al. Among authors: kanaji n. J Natl Cancer Inst. 2023 Feb 8;115(2):208-218. doi: 10.1093/jnci/djac226. J Natl Cancer Inst. 2023. PMID: 36567450 Free PMC article.
Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for EGFR L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED Analysis.
Ishihara M, Kawamura T, Namba Y, Takeyasu Y, Hasegawa Y, Sato Y, Negi Y, Oba T, Sumi T, Hirata H, Funabashi H, Oya Y, Kikuchi H, Tachihara M, Nakatani T, Harada T, Tanimura K, Nakagawa T, Takeda N, Asami T, Honjo O, Nagashima H, Yamaura T, Hata N, Kitazono M, Nishioka N, Tamiya A, Sakamori Y, Shigaki R, Kaira K, Honda R, Matsui T, Suzuki E, Ito K, Otsuka K, Yoshizumi Y, Murakami Y, Matsuno K, Inoue S, Kisohara A, Kusumoto S, Aoshima H, Kakizaki Y, Kubo A, Hata A, Ishikawa N, Hamai K, Kanaji N, Mamesaya N, Misumi T, Matsutani N, Seki N. Ishihara M, et al. Among authors: kanaji n. JTO Clin Res Rep. 2026 Feb 12;7(4):100972. doi: 10.1016/j.jtocrr.2026.100972. eCollection 2026 Apr. JTO Clin Res Rep. 2026. PMID: 41938081 Free PMC article.
96 results